May 2025 Trupanion Investor Presentation This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to, among other things, expectations, plans, prospects and financial results for Trupanion, including, but not limited to, its expectations regarding its ability to execute its business plans. These forward-looking statements are based upon the current expectations and beliefs of Trupanio ...

Core Points - Trupanion held its annual awards event on June 18, 2025, to honor the veterinary community for their significant contributions to pet health and well-being [1][3] - The awards program received over 47,000 public votes, highlighting the importance of veterinary teams in North America [2][3] - Trupanion established June 18 as Veterinary Appreciation Day in 2015 to recognize the efforts of veterinary professionals [3] Award Winners - The 2025 Veterinary Appreciation Day Awards recognized 12 winners across various categories, including Veterinarian of the Year and Veterinary Professional of the Year [4][5] - Winners included Yafen Zhen, DVM from VCA San Martin Animal Hospital, and Marie Marquez, CSR from VCA Veterinary Care Animal Hospital, among others [6][8][9] - The awards spanned multiple regions in the U.S. and Canada, showcasing the diverse talent within the veterinary field [5][7] Company Overview - Trupanion is a leading provider of medical insurance for pets in North America, with over 1,000,000 pets enrolled [11] - The company offers unlimited payouts for the life of pets and has a patented process for direct payment to veterinarians at checkout [11] - Trupanion is publicly traded on NASDAQ under the symbol "TRUP" and was founded in 2000, headquartered in Seattle, WA [11]

Core Viewpoint - Trupanion (TRUP) has received a Zacks Rank 2 (Buy) upgrade, indicating a positive outlook driven by rising earnings estimates, which significantly influence stock prices [1][2][4]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates in determining stock price movements, making it a valuable tool for investors [2][3]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in stock price movements [3]. Trupanion's Earnings Outlook - For the fiscal year ending December 2025, Trupanion is projected to earn $0.07 per share, reflecting a 130.4% increase from the previous year [7]. - Over the past three months, the Zacks Consensus Estimate for Trupanion has risen by 16.7%, indicating a positive trend in earnings expectations [7]. Zacks Rank System - The Zacks Rank system classifies stocks based on earnings estimates into five groups, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [6]. - Trupanion's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [9].

Trupanion (TRUP) FY Conference June 03, 2025 04:20 PM ET Speaker0 Okay. Good afternoon, everyone. Thanks thanks for joining us here. My name is Brandon Vasquez. For those of you who haven't met, I'm the research analyst at William Blair that covers Trupanion. And I'm required to inform you that you can go to our website at williamblair.com for a complete list of disclosures and potential conflicts of interest. With that, I'm happy to have Margie Tooth with us from Trupanion, the CEO. She's going to run us t ...

Company Overview - Trupanion, Inc. is a leader in medical insurance for pets, specifically cats and dogs, operating in the United States, Canada, and parts of Continental Europe with over 1,000,000 pets currently enrolled [2] - The company has been providing pet owners with peace of mind for over two decades, focusing on pet recovery rather than financial stress [2] - Trupanion offers unlimited payouts for the life of pets and is the only North American provider with technology to pay veterinarians directly at the time of checkout [2] Upcoming Events - Margi Tooth, the CEO and President of Trupanion, will present at the William Blair 45th Annual Growth Stock Conference on June 3, 2025, at 3:20 p.m. CT [1] - The presentation will be available via a live webcast on Trupanion's Investor Relations website [1]

Quarterly Earnings Supplement Q1 2025 Total Subscription Revenue Growth $3.1 $4.4 $5.3 $6.3 $7.6 $8.8 $9.9 $10.7 $12.0 $13.2 $14.5 $15.7 $17.0 $18.4 $20.0 $21.4 $22.9 $24.9 $27.1 $28.6 $30.1 $32.2 $34.4 $36.7 $39.1 $42.2 $44.6 $47.4 $50.2 $52.6 $56.5 $59.0 $61.5 $63.9 $67.4 $70.9 $74.2 $77.7 $82.6 $86.6 $89.5 $92.5 $99.4 $106.4 $113.3 $120.4 $127.1 $134.1 $139.8 $145.8 $152.4 $158.6 $165.2 $173.3 $182.9 $191.5 $201.1 $208.6 $219.0 $227.8 $233.1 $0 $50.0 $100.0 $150.0 $200.0 $250.0 ($ in millions) Revenue fr ...

Core Insights - Trupanion is hosting a webinar on H5N1 bird flu, focusing on its impact on pets and the veterinary community [1][2] - The webinar aims to provide veterinary professionals and pet parents with the latest information and practical guidance on avian flu in pets [2][3] Company Overview - Trupanion is a leading provider of medical insurance for pets, with over 1,000,000 pets enrolled across the United States, Canada, Europe, and Australia [7] - The company offers unlimited payouts for the life of pets and has a patented process that allows for direct payment to veterinarians at checkout [7] Webinar Details - The webinar titled "Bird Flu: What We Know Now" will be available on-demand on May 8th, 2025, and is hosted by Dr. Steve Weinrauch, Chief Veterinary/Product Officer at Trupanion [2] - Panelists include experts from various veterinary and public health organizations, discussing topics such as at-risk pet populations, virus transmission, clinical signs in pets, and preventative measures [6] Health Monitoring System - Trupanion's Pet & Public Health Early Warning Detection System uses real-time health data from over 11,000 veterinary hospitals to identify illness trends affecting companion animals [4] - The system collaborates with health authorities to proactively detect and respond to potential health threats [4]

Group 1 - Trupanion (TRUP) closed at $36.44, with a 4.1% gain over the past four weeks, and a mean price target of $54.75 indicating a 50.3% upside potential [1] - The average price targets range from a low of $41 to a high of $65, with a standard deviation of $10.66, suggesting a variability in analyst estimates [2] - Analysts show strong agreement on Trupanion's ability to report better earnings, with a positive trend in earnings estimate revisions indicating potential upside [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for Trupanion's current year earnings has increased by 64.3%, with two estimates moving higher and no negative revisions [12] - Trupanion holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [10][13]

Core Insights - Trupanion reported revenue of $341.98 million for the quarter ended March 2025, reflecting an 11.7% increase year-over-year and a surprise of +1.17% over the Zacks Consensus Estimate of $338.01 million [1] - The company's EPS was -$0.03, an improvement from -$0.16 in the same quarter last year, with a surprise of +25.00% compared to the consensus estimate of -$0.04 [1] Revenue Breakdown - Revenue from Other Business was $108.91 million, exceeding the three-analyst average estimate of $106.10 million, representing a year-over-year change of +3.7% [4] - Subscription Business revenue reached $233.06 million, slightly above the average estimate of $231.92 million, with a year-over-year increase of +15.9% [4] Operating Income - Other business adjusted operating income (non-GAAP) was reported at $1.17 million, surpassing the average estimate of $0.83 million from three analysts [4] - Subscription adjusted operating income (non-GAAP) was $30.02 million, exceeding the average estimate of $27.50 million from three analysts [4] Stock Performance - Trupanion's shares have returned -1.8% over the past month, compared to a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Company Performance - Trupanion reported a quarterly loss of $0.03 per share, better than the Zacks Consensus Estimate of a loss of $0.04, and an improvement from a loss of $0.16 per share a year ago, representing an earnings surprise of 25% [1] - The company posted revenues of $341.98 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.17% and showing an increase from year-ago revenues of $306.12 million [2] - Over the last four quarters, Trupanion has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Outlook - Trupanion shares have declined approximately 24.1% since the beginning of the year, compared to a decline of 5.3% for the S&P 500 [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimate for the coming quarter at -$0.03 on revenues of $342.04 million, and $0.09 on $1.39 billion in revenues for the current fiscal year [7] Industry Context - The Insurance - Accident and Health industry, to which Trupanion belongs, is currently in the top 25% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that the industry outlook can significantly impact stock performance [5][8]